SCHEMBL5658124

SCHEMBL5658124

CC(=O)Nc1ccccc1CCN1CCC(CN2Cc3ccccc3C2=O)CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 1/20 0.52
HTR2A P28223 1/20 0.52
TMEM97 Q5BJF2 1/20 0.52
ACHE P22303 1/20 0.45
CCR3 P51677 7/20 0.45
OPRM1 P35372 1/20 0.45
SIGMAR1 Q99720 1/20 0.45
PARP1 P09874 2/20 0.41
KDM4E B2RXH2 1/20 0.41
ALOX15 P16050 1/20 0.41
TSHR P16473 1/20 0.41
SIRT1 Q96EB6 1/20 0.41
HDAC3 O15379 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC7 Q8WUI4 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC10 Q969S8 1/20 0.41
HDAC11 Q96DB2 1/20 0.41
HDAC8 Q9BY41 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5658721 0.99 HTR1A (0.52) HTR1AHTR2ATMEM97ACHECCR3
SCHEMBL5658875 0.89 HTR1A (0.52) HTR1AHTR2ATMEM97ACHECCR3
SCHEMBL5658261 0.81 HTR1A (0.53) HTR1AHTR2ATMEM97ACHECCR3
SCHEMBL5660518 0.81 ACHE (0.54) HTR1AHTR2ATMEM97ACHECCR3
SCHEMBL5661060 0.80 HTR1A (0.53) HTR1AHTR2ATMEM97SIGMAR1
Hydrochloric Acid SCHEMBL5658391 0.80 HTR1A (0.53) HTR1AHTR2ATMEM97ACHECCR3
Hydrochloric Acid SCHEMBL5658805 0.79 KCNH2 (0.54) HTR1AHTR2ATMEM97SIGMAR1
Fumaric Acid SCHEMBL5657808 0.79 HTR1A (0.52) HTR1AHTR2ATMEM97ACHECCR3
SCHEMBL5656507 0.79 HTR1A (0.50) HTR1AHTR2ATMEM97ACHE
Fumaric Acid SCHEMBL5657801 0.79 HTR1A (0.52) HTR1AHTR2ATMEM97ACHECCR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7166617-B2 Cyclic amide derivatives MITSUBISHI PHARMA CORPORATION (JP) 2007-01-23 US disclosed
US-20030212094-A1 Novel cyclic amide derivatives MITSUBISHI PHARMA CORPORATION (JP) 2003-11-13 US disclosed
EP-1260512-A1 NOVEL CYCLIC AMIDE DERIVATIVES Mitsubishi Pharma Corporation (JP) 2002-11-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030212094-A1 Novel cyclic amide derivatives SIGMAR1, OPRM1, OPRD1 HTR1A 79/4885HTR2A 153/4885TMEM97 10/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.